November 2017 | Volume 7 | Issue 5 | ISSN: 2161-0711 conferenceseries.com Journal of Community Medicine & Health Education 1476th Conference Proceedings of 3rd World Congress on Public Health, Nutrition & Epidemiology November 13-14, 2017 Osaka, Japan Conference Series One Commerce Center-1201Orange St. #600, Wilmington, Zip 19899, Delaware, USA, Toll Free: 1-888-843-8169 Kemp House, 152 City Road, London EC1V 2NX, UK Toll Free: +0-800-014-8923 Toll Free: Japan: 81-345780247 | Singapore: 800-852-6126 / 65 8008526126 | USA/Canada: 1-650-889-4686 Email:
[email protected] |
[email protected] conferenceseries.com conferenceseries.com 1476th Conference 3rd World Congress on Public Health, Nutrition & Epidemiology November 13-14, 2017 Osaka, Japan Keynote Forum (Day 1) Page 11 Hiroshi Mizushima, J Community Med Health Educ 2017, 7:5 (Suppl) conferenceseries.com DOI: 10.4172/2161-0711-C1-029 3rd World Congress on Public Health, Nutrition & Epidemiology November 13-14, 2017 Osaka, Japan Hiroshi Mizushima National Institute of Public Health, Japan Evidence based public health to precision public health recision medicine by the personalized medicine now became possible. We can use genetic testing for drug metabolizing Penzymes such as CYPs to estimate the adverse effect or efficiency of the drug for each patient. We also can check the genetic change of a cancer to see how it acts for the particular patient. Also, recent findings suggest possible genetic background for high risk for many diseases such as cancer, hypertension, dementia, autism or allergy. These high-risk markers are effective for prevention of the disease, which is a new style of public health.